Publikationen, an denen er mitarbeitet María Pilar Civeira Murillo (12)

2008

  1. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

    Journal of Viral Hepatitis, Vol. 15, Núm. 11, pp. 782-789

2007

  1. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

    Journal of Virology, Vol. 81, Núm. 7, pp. 3662-3666

2006

  1. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins

    Journal of Viral Hepatitis, Vol. 13, Núm. 1, pp. 47-55

2001

  1. Dendritic cells infected with recombinant defective adenoviruses undergo NF-kB activation and partial maturation

    INMUNOLOGÍA, Vol. 20, Núm. 3, pp. 130-142

1998

  1. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C

    Hepatology, Vol. 28, Núm. 3, pp. 815-822

  2. Transmission of hepatitis C virus infection to tree shrews

    Virology, Vol. 244, Núm. 2, pp. 513-520

1997

  1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

    Gastroenterology, Vol. 113, Núm. 5, pp. 1647-1653

1996

  1. Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine

    AIDS Research and Human Retroviruses, Vol. 12, Núm. 11, pp. 1023-1030

  2. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: Relationship with the response to interferon treatment

    Journal of Hepatology, Vol. 25, Núm. 1, pp. 1-9

1995

  1. Interferon treatment of chronic hepatitis C: a randomised, controlled study of human lymphoblastoid alpha-interferon versus no therapy

    Lymphoblastoid alpha-interferon (Current Medical Literature Ltd), pp. 113 - 122

1994

  1. Cd4 modified synthetic peptides containing phenylalanine inhibit hiv 1 infection in vitro

    Journal of Acquired Immune Deficiency Syndromes, Vol. 7, Núm. 2

1991

  1. Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

    European Journal of Immunology, Vol. 21, Núm. 6, pp. 1555-1558